Bio-Rad Laboratories
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $649,729 | $638,476 | $610,820 | $681,184 |
Gross Profit | 355,903 | 355,719 | 326,466 | 365,900 |
EBITDA | 922,894 | -2,727,417 | 551,155 | 493,753 |
EBIT | 883,994 | -2,774,017 | 503,355 | 440,753 |
Net Income | 653,172 | -2,165,486 | 383,916 | 349,708 |
Net Change In Cash | 649,729 | 638,476 | 610,820 | 681,184 |
Free Cash Flow | 246,684 | 55,365 | 28,999 | 38,802 |
Cash | 411,753 | 407,297 | 433,331 | 403,966 |
Basic Shares | 27,985 | 28,395 | 28,537 | 28,815 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,671,262 | $2,802,249 | $2,922,545 | $2,545,626 |
Gross Profit | 1,431,346 | 1,567,330 | 1,640,661 | 1,437,822 |
EBITDA | -608,264 | -4,488,959 | 5,627,505 | 5,104,699 |
EBIT | -800,664 | -4,666,159 | 5,450,605 | 4,929,499 |
Net Income | -637,324 | -3,627,535 | 4,254,257 | 3,814,229 |
Net Change In Cash | 2,671,262 | 2,802,249 | 2,922,545 | 2,545,626 |
Cost of Revenue | -39,570 | -195,982 | 4,464 | |
Free Cash Flow | 218,263 | 80,290 | 535,718 | 476,408 |
Cash | 403,966 | 434,215 | 470,783 | 662,205 |
Basic Shares | 29,209 | 29,785 | 30,208 | 30,160 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $2.01 |
2024-06-30 | $3.11 |
2024-03-31 | $2.29 |
2023-12-31 | $3.10 |
